Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Is The Share Price Of Cashed-Up Sonic (ASX:SHL) A Buy?

Sonic Healthcare Limited (ASX:SHL) is selling one of its businesses for a profit of €30 million, is it a buy?

Sonic Healthcare Limited (ASX: SHL) is selling one of its businesses for a profit of €30 million, is it a buy?

Sonic Healthcare is one of Australia’s largest healthcare businesses, it provides laboratory services, pathology, and radiology services. It is actually the world’s third largest pathology/laboratory medicine company. It has operations in Australia, USA, Germany, Belgium, Switzerland, the United Kingdom, Ireland and New Zealand.

Sonic’s Sale

Sonic has sold its 85% stake of German business GLP Systems to US healthcare giant Abbott Laboratories (NYSE: ABT).

Sonic thinks the company’s potential will be more fully realised in partnership with a suitable partner in the IVD equipment market, and Abbott is the global leader in this market. Sonic also said that GLP is not core to Sonic’s business.

GLP Systems was an important business for Sonic because, with the help of Sonic staff and laboratories, it developed a “cutting edge” laboratory automation system which has been installed in eight Sonic laboratories in Australia, the UK and Germany with more planned. GLP Systems is expected to make around €14 million of revenue in FY19.

The sale agreement includes a long term collaboration section between Sonic and Abbott, as Sonic will continue to be an important customer of GLP.

Sonic will make an after-tax profit on the GLP Systems sale  of €30 million. However, €80 million of cash will be returned to Sonic which consists of sale proceeds and shareholder loan repayments. That money will be used to repay existing Euro debt and create additional balance sheet capacity for further laboratory acquisitions.

Is Sonic A Buy?

Sonic has been an excellent defensive business to own over the past two decades, with a reliable dividend and pleasing tailwinds thanks to an ageing population and better technology.

However, I fear that unless Sonic can make more major acquisitions into the future, its strong performance will be difficult to keep going. I like the idea of investing in businesses that have defensive earnings and have the potential for market beating growth, such as the ones in the free report below.

[ls_content_block id=”14945″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content